Dimensional Fund Advisors
CRDF icon

Dimensional Fund Advisors’s Cardiff Oncology CRDF Stock Holding History

Dimensional Fund Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6K Hold
36,650
– – ﹤0.01% 3196
2026
Q1 		$59.4K Sell
36,650
-19,060
-34% -$39.1K ﹤0.01% 3165
2025
Q4 		$157K Buy
55,710
+12
+0% +$28 ﹤0.01% 3111
2025
Q3 		$115K Hold
55,698
– – ﹤0.01% 3176
2025
Q2 		$175K Hold
55,698
– – ﹤0.01% 3133
2025
Q1 		$175K Sell
55,698
-12,781
-19% -$50.5K ﹤0.01% 3144
2024
Q4 		$297K Hold
68,479
– – ﹤0.01% 3108
2024
Q3 		$183K Buy
68,479
+49,381
+259% +$117K ﹤0.01% 3183
2024
Q2 		$42.4K Buy
19,098
+4,892
+34% +$18.4K ﹤0.01% 3325
2024
Q1 		$75.9K Hold
14,206
– – ﹤0.01% 3292
2023
Q4 		$21K Hold
14,206
– – ﹤0.01% 3386
2023
Q3 		$19.7K Sell
14,206
-17,093
-55% -$28.8K ﹤0.01% 3444
2023
Q2 		$46K Hold
31,299
– – ﹤0.01% 3412
2023
Q1 		$51.6K Buy
+31,299
New +$53.7K ﹤0.01% 3381
2022
Q3 		$62K Buy
40,163
+21,632
+117% +$52.1K ﹤0.01% 3380
2022
Q2 		$41K Buy
+18,531
New +$31K ﹤0.01% 3409
2020
Q2 		– Sell
-12,919
Closed -$13K – 3344
2020
Q1 		$13K Hold
12,919
– – ﹤0.01% 3363
2019
Q4 		$16K Sell
12,919
-7,600
-37% -$10.8K ﹤0.01% 3374
2019
Q3 		$31K Hold
20,519
– – ﹤0.01% 3403
2019
Q2 		$51K Hold
20,519
– – ﹤0.01% 3424
2019
Q1 		$77K Buy
+20,519
New +$73.4K ﹤0.01% 3391

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Dimensional Fund Advisors's CRDF Position: Q2 2026 in Review

Dimensional Fund Advisors held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 36,650 shares worth $47.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.

Dimensional Fund Advisors first reported a position in CRDF in Q1 2019 and has held it in 21 quarters since. The position peaked at $297K in Q4 2024. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Dimensional Fund Advisors held 36,650 shares of Cardiff Oncology worth $47.6K as of Q2 2026.
  • Dimensional Fund Advisors left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3196 holding.
  • Dimensional Fund Advisors first reported a position in Cardiff Oncology in Q1 2019 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's Cardiff Oncology position peaked at $297K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.